Medical News

RSS

Baxter seeks FDA BLA approval for BAX 326 rFIX protein to treat hemophilia B

Baxter International Inc. today announced that the company has submitted a biologics license application to the United States Food and Drug Administration for approval of BAX 326, a recombinant factor IX (rFIX) protein being investigated for the treatment and prophylaxis of bleeding episodes for patients over 12 years of age with hemophilia B.

From Baxter International Inc. 5 Sep 2012

Longer resuscitation could be beneficial after in-hospital cardiac arrest

New research published Online First in The Lancet suggests that increasing the duration of resuscitation efforts could improve survival in patients who arrest in hospital, challenging the common belief that extending resuscitation in patients who do not respond immediately is often futile.

5 Sep 2012

Roadmap to areas of the brain associated with affective aggression

A North Carolina State University researcher has created a roadmap to areas of the brain associated with affective aggression in mice. This roadmap may be the first step toward finding therapies for humans suffering from affective aggression disorders that lead to impulsive violent acts.

5 Sep 2012

Lawmakers in the Philippines working to negotiate compromise on reproductive health bill

"After 14 years in limbo," legislation being considered by the Philippines Congress would "requir[e] the government to provide contraceptives, information on modern family planning methods at public health centers, and comprehensive reproductive health curriculum in schools," CNN reports.

5 Sep 2012

Regular Fanconi anemia cells aren't sensitive to resveratrol

Fanconi anemia is a recessive genetic disorder affecting 1 in 350,000 babies, which leaves cells unable to repair damaged DNA. This lack of repair puts Fanconi anemia patients at high risk for developing a variety of cancers, especially leukemias and head and neck cancer.

5 Sep 2012

FDA approves Bosulif to treat chronic myelogenous leukemia

The U.S. Food and Drug Administration today approved Bosulif (bosutinib) to treat chronic myelogenous leukemia (CML), a blood and bone marrow disease that usually affects older adults.

5 Sep 2012

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

The Associated Press examines how tech-savy young doctors are changing medicine, and KHN looks at efforts to train doctors to recognize how addictions complicate other health problems.

5 Sep 2012

Drugs targeting protein TGF-β may be used to treat ovarian cancer

In the September issue of the Journal of Clinical Investigation, researchers at MD Anderson Cancer Center report that ovarian cancer cells activate the HOXA9 gene to compel stromal cells to create an environment that supports tumor growth.

5 Sep 2012

Scientists identify master regulator essential for progression and relapse of deadly brain cancer

A*STAR scientists have identified a biomarker of the most lethal form of brain tumours in adults- glioblastoma multiforme. The scientists found that by targeting this biomarker and depleting it with a potential drug, they were able to prevent the progression and relapse of the brain tumour.

5 Sep 2012

IPS examines challenges to slowing spread of HIV in Eastern Europe, Central Asia

"Despite pledges from governments across Eastern Europe and Central Asia to fight HIV/AIDS -- one of the eight Millennium Development Goals -- the region has the world's fastest-growing HIV epidemic," Inter Press Service reports in an article examining challenges to stemming the spread of the disease, particularly among injection drug users.

5 Sep 2012

FDA clears Roche's automated type-specific herpes tests

Roche announced today that it has received clearance from the U.S. Food and Drug Administration for its IgG Antibody to herpes simplex virus types 1 and 2 assays for use on cobas modular platforms. The tests are intended for use with sexually active individuals and expectant mothers as an aid in the presumptive diagnosis of HSV-1 and HSV-2 infection.

From Roche Sequencing and Life Science 5 Sep 2012

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

ImmusanT announced today that it has initiated clinical trials in New Zealand, Australia and the U.S. to evaluate Nexvax2, the first therapeutic vaccine for patients with celiac disease. Nexvax2 is designed to re-establish patients' tolerance to the toxic effects of gluten, a protein in wheat, barley and rye, and allow them to return to a normal diet.

5 Sep 2012

Democrats to spotlight health care, abortion rights support at convention

Party leaders will be touting the health overhaul passed two years ago, as well as efforts to expand contraception coverage. In addition, the platform looks ahead at issues such as health disparities, public health and HIV, Politico Pro reports.

5 Sep 2012

AlloCure commences AC607 Phase 2 clinical trial for acute kidney injury

AlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for acute kidney injury.

5 Sep 2012

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Avanir Pharmaceuticals, Inc. today announced the enrollment of the first patient in study AVR-131. The study is a Phase II clinical trial investigating the use of AVP-923 for the treatment of agitation in patients with Alzheimer's disease.

5 Sep 2012

Ebola outbreak ending in Uganda, continues to affect neighboring DR Congo

"While Ebola continues to kill in the Democratic Republic of Congo, an outbreak of the virus in neighboring Uganda appears to be coming to an end, the World Health Organization said Monday, reporting that no new cases of the deadly virus had been confirmed in Uganda for a month," the Los Angeles Times' "World Now" blog reports.

5 Sep 2012

EC grants European market authorization for Revestive to treat short bowel syndrome

Takeda Pharmaceutical Company Limited and NPS Pharmaceuticals, Inc., jointly announced today that the European Commission has granted European market authorization for the medicinal product teduglutide (trade name in Europe: Revestive) as a once-daily treatment for adult patients with short bowel syndrome.

5 Sep 2012

Green tea chemical found to boost memory

It has long been believed that drinking green tea is good for the memory. Now researchers have discovered how the chemical properties of China’s favorite drink affect the generation of brain cells, providing benefits for memory and spatial learning. The research is published in Molecular Nutrition & Food Research.

5 Sep 2012

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Global ophthalmic company OptiMedica Corp. has announced U.S. Food and Drug Administration 510(k) market clearance of its Catalys Precision Laser System for creating single-plane and multi-plane arc cuts/incisions in the cornea during cataract surgery.

5 Sep 2012

Delegates to Latin America, Caribbean Forum on AIDS, STIs discuss progress, challenges

"More than 4,000 delegates -- including government officials, health experts, community leaders, scientists, indigenous populations, youth and people living with HIV -- convened from 28-31 August in Sao Paulo, Brazil, for the 6th Latin American and Caribbean Forum on HIV/AIDS and Sexually Transmitted Infections (STIs)," UNAIDS reports in a feature story.

5 Sep 2012

Medical News

Baxter seeks FDA BLA approval for BAX 326 rFIX protein to treat hemophilia B

Longer resuscitation could be beneficial after in-hospital cardiac arrest

Roadmap to areas of the brain associated with affective aggression

Lawmakers in the Philippines working to negotiate compromise on reproductive health bill

Regular Fanconi anemia cells aren't sensitive to resveratrol

FDA approves Bosulif to treat chronic myelogenous leukemia

Young doctors seek to alter practice of medicine; Medical schools push training in addiction

Drugs targeting protein TGF-β may be used to treat ovarian cancer

Scientists identify master regulator essential for progression and relapse of deadly brain cancer

IPS examines challenges to slowing spread of HIV in Eastern Europe, Central Asia

FDA clears Roche's automated type-specific herpes tests

ImmusanT commences Nexvax2 clinical trials for celiac disease in New Zealand, Australia and the U.S.

Democrats to spotlight health care, abortion rights support at convention

AlloCure commences AC607 Phase 2 clinical trial for acute kidney injury

Avanir initiates enrollment in AVP-923 Phase II clinical trial for treatment of agitation in AD patients

Ebola outbreak ending in Uganda, continues to affect neighboring DR Congo

EC grants European market authorization for Revestive to treat short bowel syndrome

Green tea chemical found to boost memory

OptiMedica Catalys Precision Laser System for creating corneal incisions receives FDA 510(k) clearance

Delegates to Latin America, Caribbean Forum on AIDS, STIs discuss progress, challenges

The importance of ketones from a clinical and medical perspective

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Latest News